132 related articles for article (PubMed ID: 27430395)
21. Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC.
Overmeer RM; Henken FE; Snijders PJ; Claassen-Kramer D; Berkhof J; Helmerhorst TJ; Heideman DA; Wilting SM; Murakami Y; Ito A; Meijer CJ; Steenbergen RD
J Pathol; 2008 Aug; 215(4):388-97. PubMed ID: 18498117
[TBL] [Abstract][Full Text] [Related]
22. HPV E4 expression and DNA hypermethylation of CADM1, MAL, and miR124-2 genes in cervical cancer and precursor lesions.
Zummeren MV; Kremer WW; Leeman A; Bleeker MCG; Jenkins D; Sandt MV; Doorbar J; Heideman DAM; Steenbergen RDM; Snijders PJF; Kenter GG; Quint WGV; Berkhof J; Meijer CJLM
Mod Pathol; 2018 Dec; 31(12):1842-1850. PubMed ID: 30135508
[TBL] [Abstract][Full Text] [Related]
23. Alterations of ATM and CADM1 in chromosomal 11q22.3-23.2 region are associated with the development of invasive cervical carcinoma.
Mazumder Indra D; Mitra S; Roy A; Mondal RK; Basu PS; Roychoudhury S; Chakravarty R; Panda CK
Hum Genet; 2011 Dec; 130(6):735-48. PubMed ID: 21643982
[TBL] [Abstract][Full Text] [Related]
24. Gene methylation of CADM1 and MAL identified as a biomarker of high grade anal intraepithelial neoplasia.
Phillips S; Cassells K; Garland SM; Machalek DA; Roberts JM; Templeton DJ; Jin F; Poynten IM; Hillman RJ; Grulich AE; Murray GL; Tabrizi SN; Molano M; Cornall AM;
Sci Rep; 2022 Mar; 12(1):3565. PubMed ID: 35241698
[TBL] [Abstract][Full Text] [Related]
25. Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women.
Vasiljević N; Scibior-Bentkowska D; Brentnall AR; Cuzick J; Lorincz AT
Gynecol Oncol; 2014 Mar; 132(3):709-14. PubMed ID: 24508839
[TBL] [Abstract][Full Text] [Related]
26. Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial.
Verhoef VM; Bosgraaf RP; van Kemenade FJ; Rozendaal L; Heideman DA; Hesselink AT; Bekkers RL; Steenbergen RD; Massuger LF; Melchers WJ; Bulten J; Overbeek LI; Berkhof J; Snijders PJ; Meijer CJ
Lancet Oncol; 2014 Mar; 15(3):315-22. PubMed ID: 24529697
[TBL] [Abstract][Full Text] [Related]
27. Chromosomal signatures of a subset of high-grade premalignant cervical lesions closely resemble invasive carcinomas.
Wilting SM; Steenbergen RD; Tijssen M; van Wieringen WN; Helmerhorst TJ; van Kemenade FJ; Bleeker MC; van de Wiel MA; Carvalho B; Meijer GA; Ylstra B; Meijer CJ; Snijders PJ
Cancer Res; 2009 Jan; 69(2):647-55. PubMed ID: 19147580
[TBL] [Abstract][Full Text] [Related]
28. Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2/3 lesions.
De Strooper LM; Meijer CJ; Berkhof J; Hesselink AT; Snijders PJ; Steenbergen RD; Heideman DA
Cancer Prev Res (Phila); 2014 Dec; 7(12):1251-7. PubMed ID: 25281488
[TBL] [Abstract][Full Text] [Related]
29. Combined Liquid Biopsy Methylation Analysis of CADM1 and MAL in Cervical Cancer Patients.
Leffers M; Herbst J; Kropidlowski J; Prieske K; Bohnen AL; Peine S; Jaeger A; Oliveira-Ferrer L; Goy Y; Schmalfeldt B; Pantel K; Wölber L; Effenberger K; Wikman H
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010947
[TBL] [Abstract][Full Text] [Related]
30. DNA methylation for cervical cancer screening: a training set in China.
Kong L; Wang L; Wang Z; Xiao X; You Y; Wu H; Wu M; Liu P; Li L
Clin Epigenetics; 2020 Jun; 12(1):91. PubMed ID: 32576279
[TBL] [Abstract][Full Text] [Related]
31. Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia (CIN2+): a systematic review and meta-analysis.
Kelly H; Benavente Y; Pavon MA; De Sanjose S; Mayaud P; Lorincz AT
Br J Cancer; 2019 Nov; 121(11):954-965. PubMed ID: 31616037
[TBL] [Abstract][Full Text] [Related]
32. DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort.
van Leeuwen RW; Oštrbenk A; Poljak M; van der Zee AGJ; Schuuring E; Wisman GBA
Int J Cancer; 2019 Feb; 144(4):746-754. PubMed ID: 30259973
[TBL] [Abstract][Full Text] [Related]
33. Methylation in host and viral genes as marker of aggressiveness in cervical lesions: Analysis in 543 unscreened women.
Fiano V; Trevisan M; Fasanelli F; Grasso C; Marabese F; da Graça Bicalho M; de Carvalho NS; Maestri CA; Merletti F; Sacerdote C; De Marco L; Gillio-Tos A
Gynecol Oncol; 2018 Nov; 151(2):319-326. PubMed ID: 30172480
[TBL] [Abstract][Full Text] [Related]
34. Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study).
Luttmer R; De Strooper LM; Berkhof J; Snijders PJ; Dijkstra MG; Uijterwaal MH; Steenbergen RD; van Kemenade FJ; Rozendaal L; Helmerhorst TJ; Verheijen RH; Ter Harmsel WA; Van Baal WM; Graziosi PG; Quint WG; Heideman DA; Meijer CJ
Int J Cancer; 2016 Feb; 138(4):992-1002. PubMed ID: 26317579
[TBL] [Abstract][Full Text] [Related]
35. The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer.
Barrett JE; Sundström K; Jones A; Evans I; Wang J; Herzog C; Dillner J; Widschwendter M
Genome Med; 2022 Oct; 14(1):116. PubMed ID: 36258199
[TBL] [Abstract][Full Text] [Related]
36. Role of
Kremer WW; Berkhof J; Bleeker MC; Heideman DA; van Trommel NE; van Baal MW; Verhoeve HR; Meijer CJ; Kenter GG
BMJ Open; 2019 Jul; 9(7):e029017. PubMed ID: 31289088
[TBL] [Abstract][Full Text] [Related]
37. Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology-screened referral population.
Leeman A; Del Pino M; Marimon L; Torné A; Ordi J; Ter Harmsel B; Meijer CJLM; Jenkins D; Van Kemenade FJ; Quint WGV
Int J Cancer; 2019 Jan; 144(1):160-168. PubMed ID: 30098013
[TBL] [Abstract][Full Text] [Related]
38. Follow-up strategies after treatment (large loop excision of the transformation zone (LLETZ)) for cervical intraepithelial neoplasia (CIN): Impact of human papillomavirus (HPV) test.
van der Heijden E; Lopes AD; Bryant A; Bekkers R; Galaal K
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010757. PubMed ID: 25562623
[TBL] [Abstract][Full Text] [Related]
39. Complementarity between miRNA expression analysis and DNA methylation analysis in hrHPV-positive cervical scrapes for the detection of cervical disease.
Babion I; De Strooper LMA; Luttmer R; Bleeker MCG; Meijer CJLM; Heideman DAM; Wilting SM; Steenbergen RDM
Epigenetics; 2019 Jun; 14(6):558-567. PubMed ID: 30955437
[TBL] [Abstract][Full Text] [Related]
40. JAM3 methylation status as a biomarker for diagnosis of preneoplastic and neoplastic lesions of the cervix.
Yin A; Zhang Q; Kong X; Jia L; Yang Z; Meng L; Li L; Wang X; Qiao Y; Lu N; Yang Q; Shen K; Kong B
Oncotarget; 2015 Dec; 6(42):44373-87. PubMed ID: 26517242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
